Selection of patients may limit the generalizability of results from cancer trials

Acta Oncologica

Volumn 41, Issue 2, 2002, Pages 131-137

  Fosså, Sophie D ^a   Skovlund, Eva ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; PATIENT TREATMENT; TUMORS;

SURVIVAL RATES;

ONCOLOGY;

CISPLATIN; METHOTREXATE;

ADULT; ARTICLE; BLADDER CANCER; CANCER STATISTICS; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NONBIOLOGICAL MODEL; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; STATISTICAL ANALYSIS; SURVIVAL RATE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CYSTECTOMY; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; MULTICENTER STUDIES; NEOADJUVANT THERAPY; NEOPLASM STAGING; PATIENT PARTICIPATION; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; SELECTION BIAS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 0036259144     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418602753669490     Document Type: Article

References (30)

1. Selection bias in clinical trials
2. Eligibility and extrapolation in cancer clinical trials
3. Applying results of randomised trials to clinical practice: Impact of losses before randomisation
4. Accrual of radiotherapy patients to clinical trials
5. Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studies
6. Cancer patient accessions into clinical trials: A pilot investigation into some patient and physician determinants of entry
7. Doctor-patient communication about breast cancer adjuvant therapy
8. Assessment of study design in clinical trials for bladder cancer
9. Assessing non-consent bias with parallel randomized and nonrandomized clinical trials
10. Analysis of randomized and nonrandomized patients in clinical trials using the comprehensive cohort follow-up study design
11. Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials
12. Nephroblastoma: Treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial
13. A systematic overview of chemotherapy effects in breast cancer
14. A systematic overview of chemotherapy effects in colorectal cancer
15. Neo-adjuvant cisplatin, methotrexate and vinblastine hemotherapy for muscle-invasive bladder cancer: A randomised controlled trial
16. Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer
17. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer
18. Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients
19. Muscle-invasive bladder cancer treated with external beam radiotherapy: Prognostic factors
20. Five-year follow-up of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I
21. Bladder cancer: Long-term follow-up results of patients treated with radical radiation
22. Radiotherapy in the management of bladder cancer
23. Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification
24. Improved survival and reduction in local failure rates after preoperative radiotherapy
25. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: Results of a prospective randomized trial
26. Clinical trials and epidemiology
27. Falsificationism and clinical trials
28. Generalisability of results from randomised drug trials. A trial on antimanic treatment
29. Evaluation of adjuvant psychological therapy in patients with testicular cancer: Randomised controlled trial